| Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers Y Li, T Jiang, W Zhou, J Li, X Li, Q Wang, X Jin, J Yin, L Chen, Y Zhang, ... Nature communications 11 (1), 1000, 2020 | 365 | 2020 |
| Molecular characterization and clinical relevance of m6A regulators across 33 cancer types Y Li, J Xiao, J Bai, Y Tian, Y Qu, X Chen, Q Wang, X Li, Y Zhang, J Xu Molecular cancer 18, 1-6, 2019 | 338 | 2019 |
| MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features J Xu, CX Li, YS Li, JY Lv, Y Ma, TT Shao, LD Xu, YY Wang, L Du, ... Nucleic acids research 39 (3), 825-836, 2011 | 320 | 2011 |
| Systematic functional annotation of somatic mutations in cancer PKS Ng, J Li, KJ Jeong, S Shao, H Chen, YH Tsang, S Sengupta, Z Wang, ... Cancer cell 33 (3), 450-462. e10, 2018 | 286 | 2018 |
| Prioritizing candidate disease miRNAs by topological features in the miRNA target–dysregulated network: Case study of prostate cancer J Xu, CX Li, JY Lv, YS Li, Y Xiao, TT Shao, X Huo, X Li, Y Zou, QL Han, ... Molecular cancer therapeutics 10 (10), 1857-1866, 2011 | 225 | 2011 |
| Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy Y Fang, DJ McGrail, C Sun, M Labrie, X Chen, D Zhang, Z Ju, CP Vellano, ... Cancer cell 35 (6), 851-867. e7, 2019 | 207 | 2019 |
| The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types J Xu, Y Li, J Lu, T Pan, N Ding, Z Wang, T Shao, J Zhang, L Wang, X Li Nucleic acids research 43 (17), 8169-8182, 2015 | 189 | 2015 |
| Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs C Jiang, Y Li, Z Zhao, J Lu, H Chen, N Ding, G Wang, J Xu, X Li Oncotarget 7 (6), 7120, 2016 | 152 | 2016 |
| Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data Z Zhao, J Bai, A Wu, Y Wang, J Zhang, Z Wang, Y Li, J Xu, X Li Database 2015, bav082, 2015 | 126 | 2015 |
| Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression Y Li, J Xu, H Chen, J Bai, S Li, Z Zhao, T Shao, T Jiang, H Ren, C Kang, ... Nucleic acids research 41 (22), e203-e203, 2013 | 126 | 2013 |
| Functional variomics and network perturbation: connecting genotype to phenotype in cancer S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni Nature Reviews Genetics 18 (7), 395-410, 2017 | 106 | 2017 |
| The trans-omics landscape of COVID-19 P Wu, D Chen, W Ding, P Wu, H Hou, Y Bai, Y Zhou, K Li, S Xiang, P Liu, ... Nature Communications 12 (1), 4543, 2021 | 105 | 2021 |
| LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations Y Li, L Li, Z Wang, T Pan, N Sahni, X Jin, G Wang, J Li, X Zheng, Y Zhang, ... Nucleic acids research 46 (3), 1113-1123, 2018 | 102 | 2018 |
| Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers DJ McGrail, L Federico, Y Li, H Dai, Y Lu, GB Mills, S Yi, SY Lin, N Sahni Nature communications 9 (1), 1317, 2018 | 100 | 2018 |
| Proteome instability is a therapeutic vulnerability in mismatch repair-deficient cancer DJ McGrail, J Garnett, J Yin, H Dai, DJH Shih, TNA Lam, Y Li, C Sun, Y Li, ... Cancer cell 37 (3), 371-386. e12, 2020 | 97 | 2020 |
| Dynamic organization of lncRNA and circular RNA regulators collectively controlled cardiac differentiation in humans Y Li, J Zhang, C Huo, N Ding, J Li, J Xiao, X Lin, B Cai, Y Zhang, J Xu EBioMedicine 24, 137-146, 2017 | 90 | 2017 |
| MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer J Xu, T Shao, M Song, Y Xie, J Zhou, J Yin, N Ding, H Zou, Y Li, J Zhang Molecular cancer 19, 1-15, 2020 | 85 | 2020 |
| FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators J Lu, J Xu, J Li, T Pan, J Bai, L Wang, X Jin, X Lin, Y Zhang, Y Li, N Sahni, ... Nucleic acids research 46 (19), 10019-10033, 2018 | 77 | 2018 |
| Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer Y Li, Y Zhang, S Li, J Lu, J Chen, Y Wang, Y Li, J Xu, X Li Scientific reports 5 (1), 8790, 2015 | 75 | 2015 |
| Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology JX Yongsheng Li, Yunpeng Zhang, Xia Li, Song Yi Trends in Biochemical Sciences, 2019 | 74 | 2019 |
Juan XuHarbin Medical UniversityZweryfikowany adres z ems.hrbmu.edu.cn